Bennubio, Inc.

we are an emerging technology company delivering unique cell analysis systems accommodating large multi-cellular spheroids and single cell analyses at 10 – 100x flow volume and event rates. the velocyttm enables near total analyzed sample recovery for further re-analysis, dynamic cellular kinetic studies or repurpose to other workflows. we are also creating viable cell preserving, rapid enrichment technologies to purify specific cells for in vitro expansion to enable advanced immuno-oncology treatment or selectively isolate and further characterize specific circulating cells and disease states to develop higher precision diagnostics, guidance therapeutics and prediction of minimum residual disease. (the velocyt is presently not approved by us fda for in vitro diagnostic purposes)